Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation (Q44291768)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation |
scientific article |
Statements
1 reference
Conversion from intravenous to intramuscular hepatitis B immune globulin in combination with lamivudine is safe and cost-effective in patients receiving long-term prophylaxis to prevent hepatitis B recurrence after liver transplantation (English)
1 reference
Ronald W Busuttil
1 reference
Sammy Saab
1 reference
Francisco Durazo
1 reference
Steven-Huy Han
1 reference
Paul Martin
1 reference
Marc Edelstein
1 reference
Rena Hu
1 reference
Gregg Kunder
1 reference
Curtis Holt
1 reference
Leonard Goldstein
1 reference
Douglas Farmer
1 reference
Rafik M Ghobrial
1 reference
1 February 2003
1 reference
1 reference
9
1 reference
2
1 reference
182-187
1 reference
Identifiers
1 reference
1 reference